Health ❯ Pharmaceuticals ❯ Weight Loss Drugs

GLP-1 Receptor Agonists

Semaglutide Ozempic and Wegovy Adverse Effects Ozempic Market Impact Elenoglutide Mounjaro Market Trends Semaglutide and Tirzepatide Suicidal Thoughts Tirzepatide

10 ARTICLES

2w ago

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

Regulators cited a head-to-head trial that showed about an 8% relative drop in major heart events versus Lilly’s older drug Trulicity, prompting wider use for high-risk adults with type 2 diabetes.

5 ARTICLES

last yr.

Australian Study Finds Contraception Gaps and Pregnancies After GLP-1 Weight-Loss Prescriptions